# Deep Science Ventures

> Deep Science Ventures is a VC fund backing Biotechnology and Software. See 19 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 19
- Last investment: Jun 2026
- Lead investor: 11%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/deep-science-ventures
- X (Twitter): https://twitter.com/deepsciventures
- Website: http://deepscienceventures.com/
- Facebook: https://www.facebook.com/deepsciventures

Deep Science Ventures is an accelerator that works with scientists to build companies, from scratch, across domains from biochemistry to nano-tech. They provide a basic salary to fund the first 3 months of the program, followed by a £30k investment into those teams that demonstrate the commercial and technical viability of their startup. It isbased in London, United Kingdom.

## Contacts

5 contacts available for Deep Science Ventures. Shizune tracks 10 team members at Deep Science Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/deep-science-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 32% |
| Software | 4 | 21% |
| Health Care | 4 | 21% |
| Life Science | 4 | 21% |
| Hardware | 3 | 16% |

44 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 42% |
| Pre-Seed | 8 | 42% |
| Funding Round | 2 | 11% |
| Venture - Series Unknown | 1 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 12 | 63% |
| United States | 2 | 11% |
| Germany | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eirini Malliaraki | Head of Founder Community | 0 | https://shizune.co/investors/profile/eirini-malliaraki |
| Alexandra Sakatos | Venture Founder | 0 | https://shizune.co/investors/profile/alexandra-sakatos-5462 |
| Bill Yost | Venture Partner | 4 | https://shizune.co/investors/profile/bill-yost |
| Claire Thorne | Co-Chief Executive Officer | 0 | https://shizune.co/investors/profile/claire-thorne-551f |
| Dominic Falcao | Founding Director | 1 | https://shizune.co/investors/profile/dominic-falcao |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Houdini Bio | Houdini Bio develops computational synthetic biology tools that redesign DNA sequences and gene constructs for more effective genetic medicines. The company focuses on re-engineering and optimizing DNA constructs to address performance and scalability constraints in complex therapeutics. Its technology applies computational biology methods toimprove expression characteristics and manufacturing properties of genetic medicine assets. Houdini Bio works with partners developing next-generation genetic therapies who seek to enhance therapeutic index and production output. Its core offering centers on a DNA redesign engine that enables systematic exploration of sequence space to generate constructs with improved functional profiles. The company positions its capabilities for use in biopharmaceutical research and development workflows for genetic medicines. Houdini Bio concentrates on supporting organizations working on advanced genetic therapeutics that require improved construct design and manufacturability. | $1.9M | Pre-Seed | Jun 19, 2026 |  |
| Kondor | Kondor helps energy intensive industries reduce costs and emissions by identifying and optimising inefficient equipment. |  | Pre-Seed | Jul 23, 2025 |  |
| Dunia Innovation | Dunia Innovation is a creating the world's first self-driving laboratory for electrocatalytic CO2 utilization, which will drastically accelerate catalyst research. | $11.5M | Venture - Series Unknown | Oct 23, 2024 |  |
| Dunia Innovation | Dunia Innovation is a creating the world's first self-driving laboratory for electrocatalytic CO2 utilization, which will drastically accelerate catalyst research. |  | Seed | Oct 23, 2024 |  |
| Neobe Therapeutics | Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services. | $2.3M | Seed | Feb 29, 2024 |  |
| Nibiru Chain | Nibiru Chain is a breakthrough L1 blockchain and smart contract ecosystem providing superior throughput and unparalleled security. Nibiru aims to be the most developer-friendly and user-friendly smart contract ecosystem, leading the charge toward mainstream Web3 adoption by innovating at each layer of the stack: dApp development, infrastructure,consensus, a comprehensive developer toolkit, and value accrual.Since late 2022, dozens of projects have begun building on Nibiru across sectors such as DeFi, gaming, real-world assets, NFTs, developer tools, and bridges—each sharing the common mission of making interactions with digital assets fast, secure, and user-friendly for everyone.Core Token Utility: The staking and utility token of Nibiru Chain is called ‘NIBI’. This token plays a pivotal role in powering the network’s Proof-of-Stake consensus and decentralized governance, a process by which NIBI stakers can decide on and bring about changes in the network. Additionally, NIBI is utilized to secure the network and pay for computation in the form of gas fees, essential for facilitating the creation of new blocks on the chain.“Dev Gas” Royalty Mechanism: Imagine protocols like Uniswap or Aave earning half of the ETH expended on them. This distinctive feature attracts developers to Nibiru, where builders automatically earn half of the NIBI gas expended on their smart contracts, encouraging network growth and sustained development of the ecosystem. | $12M | Seed | Feb 01, 2024 |  |
| Bastion Therapeutics | Bastion Therapeutics is a preclinical stage biotechnology startup that uses proprietary platform technology to boost Tregs for the immune system | $840K |  | Sep 12, 2023 |  |
| Xonai | Xonai is a software development company that specializes in accelerated computing for data processing platforms. | $3.5M | Seed | Jun 01, 2023 |  |
| Antiverse | Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people'slives. | $3M | Seed | Mar 01, 2023 |  |
| Rhizocore Technologies | Rhizocore Technologies produces locally-adapted mycorrhizal fungi to enhance tree planting success. | $486.4K | Pre-Seed | Mar 31, 2022 |  |

10 of 19 investments shown.

## Co-investors
- [Avonmore Developments](https://shizune.co/investors/profile/avonmore-developments) — VC Fund, 3 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 3 deals together
- [Accelerate@Babraham](https://shizune.co/investors/profile/accelerate-babraham) — VC Fund, 2 deals together
- [Acequia Capital (AceCap)](https://shizune.co/investors/profile/acequia-capital) — VC Fund, 2 deals together
- [Cambridge Angels group](https://shizune.co/investors/profile/cambridge-angels-group) — VC Fund, 2 deals together
- [Elaia](https://shizune.co/investors/profile/elaia-partners) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Deep Science Ventures invest in?

Deep Science Ventures invests primarily in Biotechnology, Software and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 19 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Deep Science Ventures?

Public channels for Deep Science Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Deep Science Ventures?

The team at Deep Science Ventures includes Eirini Malliaraki (Head of Founder Community), Alexandra Sakatos (Venture Founder) and Bill Yost (Venture Partner), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co